Amado J. Zurita-Saavedra, MD

home / authors / amado-j-zurita-saavedra-md

Articles

Dr. Zurita-Saavedra on Augmenting Therapy Earlier in Prostate Cancer Treatment Journey

January 11th 2022

Amado J. Zurita-Saavedra, MD, discusses the potential benefits of augmenting therapy earlier on in the treatment of patients with newly diagnosed metastatic prostate cancer.

Dr. Zurita-Saavedra on Emerging Frontline Therapies in Metastatic HSPC

Amado J. Zurita-Saavedra, MD

December 22nd 2021

Amado J. Zurita-Saavedra, MD, discusses emerging frontline therapies in metastatic hormone-sensitive prostate cancer.

Dr. Zurita-Saavedra on Leveraging Antiandrogen Agents in Metastatic HSPC

Amado J. Zurita-Saavedra, MD

December 20th 2021

Amado J. Zurita-Saavedra, MD, discusses the utilization of the antiandrogen agents apalutamide and enzalutamide in patients with metastatic hormone-sensitive prostate cancer.

Dr. Zurita-Saavedra on Moving Therapies From mCRPC to mHSPC

Amado J. Zurita-Saavedra, MD

October 19th 2021

Amado J. Zurita-Saavedra, MD, discusses moving therapies utilized in metastatic castration-resistant prostate cancer into the treatment of patients with metastatic hormone-sensitive prostate cancer.